User profiles for "author:J Poole"

Jason Poole

VP, Research and Development at Biocept Inc.
Verified email at biocept.com
Cited by 2828

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with …

GH Crossley, JE Poole, MA Rozner… - Heart …, 2011 - heartrhythmjournal.com
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert
Consensus Statement on the Perioperative Management of Patients with Implantable …

Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)

JC Poole, LG Andrews, TO Tollefsbol - Gene, 2001 - Elsevier
Recent interest in the regulation of telomerase, the enzyme that maintains chromosomal
termini, has lead to the discovery and characterization of the catalytic subunit of telomerase …

[HTML][HTML] Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure

GH Bardy, KL Lee, DB Mark, JE Poole… - … England Journal of …, 2005 - Mass Medical Soc
Background Sudden death from cardiac causes remains a leading cause of death among
patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable …

[HTML][HTML] Prognostic importance of defibrillator shocks in patients with heart failure

JE Poole, GW Johnson, AS Hellkamp… - … England Journal of …, 2008 - Mass Medical Soc
Background Patients with heart failure who receive an implantable cardioverter–defibrillator
(ICD) for primary prevention (ie, prevention of a first life-threatening arrhythmic event) may …

Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA …

DL Packer, DB Mark, RA Robb, KH Monahan… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF),
but its effects on long-term mortality and stroke risk are uncertain. Objective To determine …

Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE …

JE Poole, MJ Gleva, T Mela, MK Chung, DZ Uslan… - Circulation, 2010 - Am Heart Assoc
Background—Prospective studies defining the risk associated with pacemaker or
implantable cardioverter-defibrillator replacement surgeries do not exist. These procedures …

[PDF][PDF] CONSENSUS DOCUMENT

…, H Burri, JC Nielsen, MG Bongiorni, J Poole… - European Heart …, 2020 - rythmolyon.fr
Pacemakers, implantable cardiac defibrillators (ICDs), and cardiac resynchronization
therapy (CRT) devices are lifesaving treatments for a number of cardiac conditions. Device …

An enhanced MITOMAP with a global mtDNA mutational phylogeny

E Ruiz-Pesini, MT Lott, V Procaccio… - Nucleic acids …, 2007 - academic.oup.com
The MITOMAP () data system for the human mitochondrial genome has been greatly
enhanced by the addition of a navigable mutational mitochondrial DNA (mtDNA) …

Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial

DB Mark, KJ Anstrom, S Sheng, JP Piccini, KN Baloch… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is more effective than drug therapy in restoring sinus rhythm in
patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) …